[Primary prevention of cerebrovascular disease].
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, México, D.F.
Carlos
C
Cantú
Oscar
O
Talamás
Alberto
A
Mejía
Jerónimo
J
Rodríguez
Luis Manuel
LM
Murillo
Miguel
M
Osorno
Luis
L
Miranda
Antonio
A
Araúz
Fernando
F
Barinagarrementeria
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001241:Aspirin / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000150:complications / Q000453:epidemiology; D002561:Cerebrovascular Disorders / Q000453:epidemiology / Q000517:prevention & control*; D015897:Comorbidity; D003278:Contraceptives, Oral, Hormonal / Q000009:adverse effects; D003920:Diabetes Mellitus / Q000453:epidemiology / Q000628:therapy; D019317:Evidence-Based Medicine; D005260:Female; D020249:Hormone Replacement Therapy; D006801:Humans; D020138:Hyperhomocysteinemia / Q000453:epidemiology / Q000628:therapy; D006949:Hyperlipidemias / Q000453:epidemiology / Q000628:therapy; D006973:Hypertension / Q000453:epidemiology / Q000628:therapy; D020766:Intracranial Embolism / Q000209:etiology; D008019:Life Style; D008297:Male; D008875:Middle Aged; D012307:Risk Factors; D012907:Smoking / Q000009:adverse effects / Q000453:epidemiology
D003278:Contraceptives, Oral, Hormonal; D001241:Aspirin